Regenxbio (RGNX) Profit After Tax (2014 - 2026)

Regenxbio's Profit After Tax history runs 12 years deep, the most recent figure standing at -$67.1 million for Q4 2025.

• In Q4 2025, Profit After Tax fell 41.26% year-over-year to -$67.1 million; the TTM figure through Dec 2025 stood at -$193.8 million (up 12.21% YoY), while the FY2025 annual figure was -$193.8 million, up 13.24% from the prior year.
• Profit After Tax for Q4 2025 stood at -$67.1 million, down from -$61.9 million in the prior quarter.
• The five-year high for Profit After Tax was $294.0 million in Q4 2021, with the low at -$86.1 million in Q1 2022.
• The 5-year median for Profit After Tax is -$60.6 million (2023), against an average of -$41.5 million.
• Peak annual rise in Profit After Tax reached 735.85% in 2021, while the deepest fall reached 764.37% in 2021.
• Regenxbio's Profit After Tax stood at $294.0 million in 2021, then sank by 115.05% to -$44.2 million in 2022, then sank by 60.18% to -$70.9 million in 2023, then surged by 32.99% to -$47.5 million in 2024, then sank by 41.26% to -$67.1 million in 2025.
• Business Quant data shows RGNX's Profit After Tax at -$67.1 million in Q4 2025, -$61.9 million in Q3 2025, and -$70.9 million in Q2 2025.